Literature DB >> 29128905

Down Syndrome iPSC-Derived Astrocytes Impair Neuronal Synaptogenesis and the mTOR Pathway In Vitro.

Bruno H S Araujo1,2, Carolini Kaid3, Janaina S De Souza4, Sérgio Gomes da Silva5,6, Ernesto Goulart3, Luiz C J Caires3, Camila M Musso3, Laila B Torres7, Adriano Ferrasa8,9, Roberto Herai9, Mayana Zatz3, Oswaldo K Okamoto3, Esper A Cavalheiro10.   

Abstract

Several methods have been used to study the neuropathogenesis of Down syndrome (DS), such as mouse aneuploidies, post mortem human brains, and in vitro cell culture of neural progenitor cells. More recently, induced pluripotent stem cell (iPSC) technology has offered new approaches in investigation, providing a valuable tool for studying specific cell types affected by DS, especially neurons and astrocytes. Here, we investigated the role of astrocytes in DS developmental disease and the impact of the astrocyte secretome in neuron mTOR signaling and synapse formation using iPSC derived from DS and wild-type (WT) subjects. We demonstrated for the first time that DS neurons derived from hiPSC recapitulate the hyperactivation of the Akt/mTOR axis observed in DS brains and that DS astrocytes may play a key role in this dysfunction. Our results bear out that 21 trisomy in astrocytes contributes to neuronal abnormalities in addition to cell autonomous dysfunctions caused by 21 trisomy in neurons. Further research in this direction will likely yield additional insights, thereby improving our understanding of DS and potentially facilitating the development of new therapeutic approaches.

Entities:  

Keywords:  Astrocyte; Down syndrome; Induced pluripotent stem cell; mTOR pathway

Mesh:

Substances:

Year:  2017        PMID: 29128905     DOI: 10.1007/s12035-017-0818-6

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  45 in total

1.  Nonneuronal cells regulate synapse formation in the vestibular sensory epithelium via erbB-dependent BDNF expression.

Authors:  Maria E Gómez-Casati; Joshua C Murtie; Carlos Rio; Konstantina Stankovic; M Charles Liberman; Gabriel Corfas
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-13       Impact factor: 11.205

2.  A more efficient method to generate integration-free human iPS cells.

Authors:  Keisuke Okita; Yasuko Matsumura; Yoshiko Sato; Aki Okada; Asuka Morizane; Satoshi Okamoto; Hyenjong Hong; Masato Nakagawa; Koji Tanabe; Ken-ichi Tezuka; Toshiyuki Shibata; Takahiro Kunisada; Masayo Takahashi; Jun Takahashi; Hiroh Saji; Shinya Yamanaka
Journal:  Nat Methods       Date:  2011-04-03       Impact factor: 28.547

3.  Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling.

Authors:  Yutaka Midorikawa; Shumpei Ishikawa; Hiroko Iwanari; Takeshi Imamura; Hirohiko Sakamoto; Kohei Miyazono; Tatsuhiko Kodama; Masatoshi Makuuchi; Hiroyuki Aburatani
Journal:  Int J Cancer       Date:  2003-02-10       Impact factor: 7.396

4.  Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome.

Authors:  Fabian Fernandez; Wade Morishita; Elizabeth Zuniga; James Nguyen; Martina Blank; Robert C Malenka; Craig C Garner
Journal:  Nat Neurosci       Date:  2007-02-25       Impact factor: 24.884

5.  Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis.

Authors:  Karen S Christopherson; Erik M Ullian; Caleb C A Stokes; Christine E Mullowney; Johannes W Hell; Azin Agah; Jack Lawler; Deane F Mosher; Paul Bornstein; Ben A Barres
Journal:  Cell       Date:  2005-02-11       Impact factor: 41.582

Review 6.  Epilepsy in children with Down syndrome.

Authors:  Ravindra Arya; Madhulika Kabra; Sheffali Gulati
Journal:  Epileptic Disord       Date:  2011-03       Impact factor: 1.819

7.  Deficits in human trisomy 21 iPSCs and neurons.

Authors:  Jason P Weick; Dustie L Held; George F Bonadurer; Matthew E Doers; Yan Liu; Chelsie Maguire; Aaron Clark; Joshua A Knackert; Katharine Molinarolo; Michael Musser; Lin Yao; Yingnan Yin; Jianfeng Lu; Xiaoqing Zhang; Su-Chun Zhang; Anita Bhattacharyya
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

Review 8.  Mammalian target of rapamycin (mTOR) pathways in neurological diseases.

Authors:  Michael Wong
Journal:  Biomed J       Date:  2013 Mar-Apr       Impact factor: 4.910

9.  mTOR supports long-term self-renewal and suppresses mesoderm and endoderm activities of human embryonic stem cells.

Authors:  Jiaxi Zhou; Pei Su; Lu Wang; Joanna Chen; Maike Zimmermann; Olga Genbacev; Olubunmi Afonja; Mary C Horne; Tetsuya Tanaka; Enkui Duan; Susan J Fisher; Jiayu Liao; Jie Chen; Fei Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-28       Impact factor: 11.205

10.  A role for thrombospondin-1 deficits in astrocyte-mediated spine and synaptic pathology in Down's syndrome.

Authors:  Octavio Garcia; Maria Torres; Pablo Helguera; Pinar Coskun; Jorge Busciglio
Journal:  PLoS One       Date:  2010-12-02       Impact factor: 3.240

View more
  19 in total

1.  Challenges and Opportunities for Translation of Therapies to Improve Cognition in Down Syndrome.

Authors:  Sarah E Lee; Monica Duran-Martinez; Sabina Khantsis; Diana W Bianchi; Faycal Guedj
Journal:  Trends Mol Med       Date:  2019-11-07       Impact factor: 11.951

2.  Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.

Authors:  Sarah Logan; Thiago Arzua; Scott G Canfield; Emily R Seminary; Samantha L Sison; Allison D Ebert; Xiaowen Bai
Journal:  Compr Physiol       Date:  2019-03-14       Impact factor: 9.090

Review 3.  Astrocyte: A Foe or a Friend in Intellectual Disability-Related Diseases.

Authors:  Busong Wang; Lu Zou; Min Li; Liang Zhou
Journal:  Front Synaptic Neurosci       Date:  2022-06-23

4.  APP and DYRK1A regulate axonal and synaptic vesicle protein networks and mediate Alzheimer's pathology in trisomy 21 neurons.

Authors:  Chun-I Wu; Elizabeth A Vinton; Richard V Pearse; Keunjung Heo; Aimee J Aylward; Yi-Chen Hsieh; Yan Bi; Sopefoluwa Adeleye; Seeley Fancher; Duc M Duong; Nicholas T Seyfried; Thomas L Schwarz; Tracy L Young-Pearse
Journal:  Mol Psychiatry       Date:  2022-02-23       Impact factor: 13.437

Review 5.  Cell models for Down syndrome-Alzheimer's disease research.

Authors:  Yixing Wu; Nicole R West; Anita Bhattacharyya; Frances K Wiseman
Journal:  Neuronal Signal       Date:  2022-04-08

6.  Human iPSC-derived Down syndrome astrocytes display genome-wide perturbations in gene expression, an altered adhesion profile, and increased cellular dynamics.

Authors:  Blandine Ponroy Bally; W Todd Farmer; Emma V Jones; Selin Jessa; J Benjamin Kacerovsky; Alexandre Mayran; Huashan Peng; Julie L Lefebvre; Jacques Drouin; Arnold Hayer; Carl Ernst; Keith K Murai
Journal:  Hum Mol Genet       Date:  2020-03-27       Impact factor: 6.150

Review 7.  Stem cell models of human synapse development and degeneration.

Authors:  Emily S Wilson; Karen Newell-Litwa
Journal:  Mol Biol Cell       Date:  2018-11-26       Impact factor: 4.138

8.  A human isogenic iPSC-derived cell line panel identifies major regulators of aberrant astrocyte proliferation in Down syndrome.

Authors:  Keiji Kawatani; Toshihiko Nambara; Nobutoshi Nawa; Hidetaka Yoshimatsu; Haruna Kusakabe; Katsuya Hirata; Akira Tanave; Kenta Sumiyama; Kimihiko Banno; Hidetoshi Taniguchi; Hitomi Arahori; Keiichi Ozono; Yasuji Kitabatake
Journal:  Commun Biol       Date:  2021-06-14

9.  Overproduction of hydrogen sulfide, generated by cystathionine β-synthase, disrupts brain wave patterns and contributes to neurobehavioral dysfunction in a rat model of down syndrome.

Authors:  Theodora Panagaki; Laura Lozano-Montes; Lucia Janickova; Karim Zuhra; Marcell P Szabo; Tomas Majtan; Gregor Rainer; Damien Maréchal; Yann Herault; Csaba Szabo
Journal:  Redox Biol       Date:  2022-01-13       Impact factor: 10.787

10.  Discordant congenital Zika syndrome twins show differential in vitro viral susceptibility of neural progenitor cells.

Authors:  Luiz Carlos Caires-Júnior; Ernesto Goulart; Uirá Souto Melo; Bruno Henrique Silva Araujo; Lucas Alvizi; Alessandra Soares-Schanoski; Danyllo Felipe de Oliveira; Gerson Shigeru Kobayashi; Karina Griesi-Oliveira; Camila Manso Musso; Murilo Sena Amaral; Lucas Ferreira daSilva; Renato Mancini Astray; Sandra Fernanda Suárez-Patiño; Daniella Cristina Ventini; Sérgio Gomes da Silva; Guilherme Lopes Yamamoto; Suzana Ezquina; Michel Satya Naslavsky; Kayque Alves Telles-Silva; Karina Weinmann; Vanessa van der Linden; Helio van der Linden; João Ricardo Mendes de Oliveira; Nivia Maria Rodrigues Arrais; Adriana Melo; Thalita Figueiredo; Silvana Santos; Joanna Goes Castro Meira; Saulo Duarte Passos; Roque Pacheco de Almeida; Ana Jovina Barreto Bispo; Esper Abrão Cavalheiro; Jorge Kalil; Edécio Cunha-Neto; Helder Nakaya; Robert Andreata-Santos; Luis Carlos de Souza Ferreira; Sergio Verjovski-Almeida; Paulo Lee Ho; Maria Rita Passos-Bueno; Mayana Zatz
Journal:  Nat Commun       Date:  2018-02-02       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.